Real-World Drug Retention and Safety of Ustekinumab in Patients With Inflammatory Bowel Disease in Qatar: A Retrospective Cohort Study
Cureus · 30.06.2026
DOI: 10.7759/cureus.111855 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cureus, erschienen am 30.06.2026. Verfasst von Abdulwahab Hamid und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT.
- College of Medicine, Qatar University, Doha, QAT.
- Internal Medicine, Hamad Medical Corporation, Doha, QAT.
- Internal Medicine Residency Program, Medical Education, Hamad Medical Corporation, Doha, QAT.
Zitieren
APA
Hamid, A., Badi, A., Ayash, A., Bensuleiman, Y., Mezhoud, S., Hassan, M. A., Battah, A., Abu Ageila, M., Kday, A., & Almohannadi, M. (2026). Real-World Drug Retention and Safety of Ustekinumab in Patients With Inflammatory Bowel Disease in Qatar: A Retrospective Cohort Study. Cureus. https://doi.org/10.7759/cureus.111855
Vancouver
Hamid A, Badi A, Ayash A, Bensuleiman Y, Mezhoud S, Hassan MA, et al. Real-World Drug Retention and Safety of Ustekinumab in Patients With Inflammatory Bowel Disease in Qatar: A Retrospective Cohort Study. Cureus. 2026. doi:10.7759/cureus.111855
BibTeX
@article{Hamid2026,
author = {Hamid, Abdulwahab and Badi, Ahmed and Ayash, Ahmad and Bensuleiman, Yahaya and Mezhoud, Souraia and Hassan, Mohammed Abderahim and Battah, Alia and Abu Ageila, Munir and Kday, Abdurahman and Almohannadi, Muneera},
title = {Real-World Drug Retention and Safety of Ustekinumab in Patients With Inflammatory Bowel Disease in Qatar: A Retrospective Cohort Study},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.111855}
}
EUVIMED